Warner Biddle: Building a commercial model for CAR-T in autoimmune care

In this episode of the Ori Spotlight Podcast, Jason C. Foster welcomes Warner Biddle, CEO of Kyverna Therapeutics, to explore how autologous CAR-T therapies can be delivered safely, efficiently, and at scale in autoimmune disease. Warner shares Kyverna’s approach to designing a commercially viable treatment model — one that prioritizes outpatient care, streamlined manufacturing, and real-world practicality. They discuss what it means to bring complex therapies into community settings, how Kyverna is tailoring its rollout strategy by indication, and why the future of CAR-T in autoimmune disease depends as much on delivery as it does on data. Connect with Warner:

You can listen to Warner Biddle: Building a commercial model for CAR-T in autoimmune care online on Radio and Podcast. Open the player on this page to stream the available audio.

Warner Biddle: Building a commercial model for CAR-T in autoimmune care is an episode from Ori Spotlight by Ori Biotech.

This episode is 00:40:41 long.

This episode was published on Sep 2, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Ori Spotlight when more episodes are available from the podcast feed.